Insurance
Latest News
April 29th 2025
Early actions by the new administration signal major changes in health policy, taxes, and pharmaceutical pricing.
More News
Pitt Study Examines Cost-Effectiveness of Medicare Drug Plans in Schizophrenia and Bipolar Disorder
February 19th 2013A new study published online today in The American Journal of Managed Care found that in Medicare Part D, generic drug coverage was cost-saving compared to no coverage in bipolar disorder and schizophrenia, while also improving health outcomes. Researchers from the University of Pittsburgh School of Medicine, the Pitt Graduate School of Public Health, and Western Psychiatric Institute and Clinic of UPMC note that policymakers and insurers should consider generic-only coverage, rather than no gap coverage, to both conserve healthcare resources and improve health.
Read More
Short-Term Costs Associated With Primary Prophylactic G-CSF Use During Chemotherapy
Granulocyte colony-stimulating factor therapy reduces hospitalizations and improves chemotherapy administration in elderly breast cancer patients, but increases overall Medicare costs during first year of therapy.
Read More
Cost-Effectiveness of Medicare Drug Plans in Schizophrenia and Bipolar Disorder
In Medicare Part D, generic drug coverage was cost saving compared with no coverage in bipolar disorder and schizophrenia while improving health outcomes.
Read More
